XML 159 R108.htm IDEA: XBRL DOCUMENT v3.25.2
Supplemental Financial Information - Schedule of Supplemental Statement of Cash Flows (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Cash flows from operating activities          
Net income $ 328.1 $ 149.3 $ 486.7 $ 248.1  
Adjustments to reconcile net income to net cash flows from operating activities:          
Depreciation and amortization     94.6 90.8  
Equity-based compensation 92.9 125.2 196.4 233.5  
Non-cash performance allocations and incentive fees     (250.6) 146.2  
Non-cash principal investment (income) loss     32.6 (145.6)  
Other non-cash amounts     36.8 (1.5)  
Purchases of investments     (144.3) (180.1)  
Proceeds from the sale of investments     469.6 185.1  
Payments of contingent consideration     (1.0) (1.5)  
Changes in deferred taxes, net     (16.5) (42.5)  
Change in due from affiliates and other receivables     (16.3) (21.2)  
Change in deposits and other     (24.9) (7.8)  
Change in accounts payable, accrued expenses and other liabilities     39.1 37.1  
Change in accrued compensation and benefits     (116.2) (277.4)  
Change in due to affiliates     23.6 (2.1)  
Change in lease right-of-use assets and lease liabilities     (6.3) (4.0)  
Change in deferred revenue     57.6 (9.8)  
Net cash used in operating activities     (520.9) (1,198.6)  
Cash flows from investing activities          
Purchases of corporate treasury investments     0.0 5.0  
Purchases of fixed assets, net     (34.2) (31.9)  
Net cash used in investing activities     (34.2) (36.9)  
Cash flows from financing activities          
Borrowings under credit facilities     0.0 10.4  
Repayments under credit facilities     0.0 (10.4)  
Payments on CLO borrowings     (40.1) (36.0)  
Proceeds from CLO borrowings, net of financing costs     15.1 0.0  
Dividends to common stockholders     (252.7) (252.3)  
Payment of deferred consideration for Carlyle Holdings units     0.0 (68.8)  
Contributions from non-controlling interest holders     231.3 120.4  
Distributions to non-controlling interest holders     (198.4) (45.6)  
Common shares repurchased and net share settlement of equity-based awards     (280.1) (328.3)  
Change in due to/from affiliates financing activities     (3.4) (0.7)  
Net cash provided by financing activities     526.8 717.2  
Effect of foreign exchange rate changes     38.7 (6.7)  
Increase (decrease) in cash, cash equivalents and restricted cash     10.4 (525.0)  
Cash, cash equivalents and restricted cash, beginning of period     1,266.5 1,442.1  
Cash, cash equivalents and restricted cash, end of period 1,276.9 917.1 1,276.9 917.1  
Reconciliation of cash, cash equivalents and restricted cash, end of period:          
Cash and cash equivalents 1,275.8 914.8 1,275.8 914.8 $ 1,266.0
Restricted cash 1.1 2.3 1.1 2.3 0.5
Total cash, cash equivalents and restricted cash, end of period 1,276.9 917.1 1,276.9 917.1 1,266.5
Cash and cash equivalents held at Consolidated Funds 463.1 1,047.5 463.1 1,047.5 830.4
Consolidated Operating Entities          
Cash flows from operating activities          
Net income     464.8 239.7  
Adjustments to reconcile net income to net cash flows from operating activities:          
Depreciation and amortization     94.6 90.8  
Equity-based compensation     196.4 233.5  
Non-cash performance allocations and incentive fees     (252.4) 145.8  
Non-cash principal investment (income) loss     33.5 (144.5)  
Other non-cash amounts     36.8 (1.5)  
Purchases of investments     (481.8) (383.0)  
Proceeds from the sale of investments     499.5 271.1  
Payments of contingent consideration     (1.0) (1.5)  
Changes in deferred taxes, net     (16.5) (42.5)  
Change in due from affiliates and other receivables     (16.5) (19.7)  
Change in deposits and other     (25.0) (7.8)  
Change in accounts payable, accrued expenses and other liabilities     39.1 37.1  
Change in accrued compensation and benefits     (116.2) (277.4)  
Change in due to affiliates     23.6 (2.1)  
Change in lease right-of-use assets and lease liabilities     (6.3) (4.0)  
Change in deferred revenue     57.6 (9.8)  
Net cash used in operating activities     530.2 124.2  
Cash flows from investing activities          
Purchases of corporate treasury investments     0.0 5.0  
Purchases of fixed assets, net     (34.2) (31.9)  
Net cash used in investing activities     (34.2) (36.9)  
Cash flows from financing activities          
Borrowings under credit facilities     0.0 10.4  
Repayments under credit facilities     0.0 (10.4)  
Payments on CLO borrowings     (40.1) (36.0)  
Proceeds from CLO borrowings, net of financing costs     15.1 0.0  
Dividends to common stockholders     (252.7) (252.3)  
Payment of deferred consideration for Carlyle Holdings units     0.0 (68.8)  
Contributions from non-controlling interest holders     91.4 116.4  
Distributions to non-controlling interest holders     (48.6) (45.6)  
Common shares repurchased and net share settlement of equity-based awards     (280.1) (328.3)  
Change in due to/from affiliates financing activities     (0.5) 7.3  
Net cash provided by financing activities     (515.5) (607.3)  
Effect of foreign exchange rate changes     29.9 (5.0)  
Increase (decrease) in cash, cash equivalents and restricted cash     10.4 (525.0)  
Cash, cash equivalents and restricted cash, beginning of period     1,266.5 1,442.1  
Cash, cash equivalents and restricted cash, end of period 1,276.9 917.1 1,276.9 917.1  
Reconciliation of cash, cash equivalents and restricted cash, end of period:          
Cash and cash equivalents 1,275.8 914.8 1,275.8 914.8  
Restricted cash 1.1 2.3 1.1 2.3  
Total cash, cash equivalents and restricted cash, end of period 1,276.9 917.1 1,276.9 917.1 $ 1,266.5
Cash and cash equivalents held at Consolidated Funds $ 463.1 $ 1,047.5 $ 463.1 $ 1,047.5